Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors.
Sponsor: IVI Madrid
Summary
The objective of this trial is to determine whether the use of letrozole during the luteal phase in oocyte donors diminishes the ovarian volume, as well as to evaluate its effect on the duration of the luteal phase, taking into account hormonal and biochemical markers. Two groups will be established with random allocation of patients and 1:1 proportionality, as follows: * Control group: No specific treatment. * Study group: Oral administration of letrozole 5 mg (each capsule is 2.5 mg) once a day for 5 days starting on the night of the follicular puncture.
Official title: Clinical and Endocrinological Effects of Letrozole During the Luteal Phase After Controlled Ovarian Stimulation in Oocyte Donors: a Low Interventional, Randomized, Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 34 Years
Study Type
INTERVENTIONAL
Enrollment
152
Start Date
2023-12-15
Completion Date
2025-05-31
Last Updated
2025-05-21
Healthy Volunteers
Yes
Conditions
Interventions
Administration of letrozole
Oral administration of letrozole 5 mg (each capsule is 2.5 mg) once a day for 5 days starting on the night of the follicular puncture.
Locations (1)
IVI-Madrid
Madrid, Spain